The FM-TTFields Platform
Frequency-Modulated Tumor Treating Fields: Precision Field-Shaping in Oncology and Fibrosis Research
Next-Generation Precision
While traditional Tumor Treating Fields (TTFields) utilize fixed frequencies to disrupt mitotic spindles in cancer cells, Fibro-Resolve’s FM-TTFields platform introduces proprietary frequency modulation and field-shaping algorithms.
Our engineering focus allows for the precise targeting of TGF-β mediated disease pathways, providing a non-invasive solution for complex fibrotic conditions and solid tumor microenvironments.
All development is conducted under a strict Quality Management System (QMS) framework to ensure data integrity and design control.
Mechanism of Action
Our research focuses on the intersection of bioelectric fields and cellular signaling to arrest disease progression through three primary vectors:
- Mitotic Arrest: Direct disruption of spindle microtubule assembly in hyper-proliferative cells.
- Immune Signalling: Induced cytoskeletal disruption leading to inflammasome recognition of micro-DNA.
- Pathway Inhibition: Targeted disruption of fibrotic signaling in TGF-β mediated disease states.
Intellectual Property & Foundational Framework
The FM-TTFields technology platform is protected by a robust portfolio of domestic and international patent filings covering our unique bioelectric algorithms and delivery systems.
Detailed patent and application data are restricted to qualified institutional partners and are available for review under a standard Non-Disclosure Agreement (NDA).
Inquire Regarding IP Access →Development Pipeline
| Clinical Research Focus | Mechanism | Development Stage |
|---|---|---|
| Solid Tumor Oncology | Mitotic Spindle Disruption | Phase 0 - Engineering |
| Fibrotic Disease | TGF-β Pathway Decoupling | Pre-Clinical Research |
| Immunotherapeutic Potentiation | Nuclear Membrane Rupture | Concept Exploration |
From Research to Reality
Explore how our engineering solutions are pioneering scientific discoveries with a new generation of bioelectric medical devices..
